CJC-1295 (without DAC) and Oxandrolone Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Oxandrolone have a synergistic interaction with 47% confidence. CJC-1295 (without DAC) and Oxandrolone work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Oxandrolone

Oral Anabolic Steroid | Lean Mass & Recovery

Oxandrolone exerts its anabolic effects primarily through binding to the intracellular androgen receptor (AR), promoting nitrogen retention and protein synthesis in skeletal muscle tissue. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, which means it does not cause estrogen-mediated water retention or gynecomastia.

Half-life: ~9-10 hours Typical dose: 20-50 mg/day (male), 5-20 mg/day (female) anabolic, healing
5 alpha reductaseandrogen receptoraromataseshbg androgeniccarcinogenic riskhepatotoxichpta suppressive
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
GI Tract
low
Pituitary
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), Oxandrolone). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Oxandrolone). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Oxandrolone?

Yes, CJC-1295 (without DAC) and Oxandrolone can generally be taken together. CJC-1295 (without DAC) and Oxandrolone work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 (without DAC) and Oxandrolone safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Oxandrolone?

CJC-1295 (without DAC) and Oxandrolone work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Oxandrolone?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Oxandrolone has a half-life of ~9-10 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Oxandrolone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.